Development and evaluation of an algorithm in Medication Management for best practice. Effectiveness of the intervention and translation into standard care for nursing home residents-AMBER study
Not Applicable
Recruiting
- Conditions
- Multimorbidity
- Registration Number
- DRKS00010995
- Lead Sponsor
- Elefanten-Apotheke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Residency in a nursing home facility, multimorbidity (at least 2 chronic diseases), polymedication (at least 5 chronic systemic available medications), signed informed consent
Exclusion Criteria
participation in other clinical studies at present time
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the reduction of the detected drug-related problems (DRPs), using the algorithm. DRPs are measured at time of the Medication Review (t0) and classified according PCNE (Pharmaceutical Care Network Europe) version 8.01. A follow-up is performed three month after the intervention (t1).
- Secondary Outcome Measures
Name Time Method - Drug-related problems classified according to PCNE version 8.01 (number and type)<br>- Measurement of physicians’ and nurses’ acceptance by using an acceptance form, classified according to PCNE version 8.01<br>- Number of drug-related problems classified according to PCNE version 8.01, detected by an Advanced Medication Review<br>- Reproducibility of analysis and feasibility of the algorithm (feedback survey, time spending, inter-rater reliability)<br>